Early safety check: does new pill change how your body handles cholesterol drugs?
NCT ID NCT07097831
Summary
This was a small, early-stage study to see how a new drug called HRS-1301 affects the way the body processes a common cholesterol-lowering medicine (rosuvastatin). It involved 16 healthy adults to measure drug levels in the blood and check for safety. The main goal was to gather basic information on potential drug interactions before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
Conditions
Explore the condition pages connected to this study.